1323-胃癌化疗联合免疫治疗的T细胞克隆动态研究 episode artwork

EPISODE · Jul 23, 2026 · 28 MIN

1323-胃癌化疗联合免疫治疗的T细胞克隆动态研究

from 聊聊Sci

这项研究通过对晚期胃癌患者进行连续活检和单细胞测序,揭示了化疗联合免疫治疗产生持久疗效的免疫机制。研究发现,长生存期患者(慢进展者)在治疗过程中能够维持具有肿瘤反应性且呈前体耗竭状态的特定T细胞克隆。这些关键的T细胞克隆在治疗前已存在于外周血中,并在免疫治疗后有效浸润至肿瘤组织。此外,肿瘤微环境内B细胞的增加及其与T细胞间的共刺激信号交互,为这些抗癌T细胞的持久存在提供了重要支持。该成果为预测胃癌免疫治疗效果提供了生物标志物,并为优化治疗方案提供了理论依据。References:Wright S J, Kang S, An M, et al. Differential T cell clonal dynamics underlie outcomes to frontline chemoimmunotherapy in advanced gastric cancer[J]. Cell Reports Medicine, 2025.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Jul 23, 2026

Embed this episode

Ready to play

1323-胃癌化疗联合免疫治疗的T细胞克隆动态研究

0:00 28:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 28 minutes long.

When was this 聊聊Sci episode published?

This episode was published on July 23, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!